Skip to content

Feed Screener MCP Methodology

⌘K

EN

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
AMF · FR
BAFIN · DE

Product

Ask the record
Help
Methodology
Signal backtests
Terms
Privacy notice
Object to processing

Language

English Español Français

Feed Screener MCP Methodology

English Español Français

Pricing Sign in

Schwer Heinz — Veraxa Biotech AG - Post de-SPAC insider · InsiderLens

/ / Schwer Heinz

Schwer Heinz

Chief Business Officer at Veraxa Biotech AG - Post de-SPAC · on record since Jun 9, 2026

Insider trading activity of Schwer Heinz

No transactions on record for Schwer Heinz.

Track record of Schwer Heinz

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Schwer Heinz

Co-insiders of Schwer Heinz

Antz Christoph RudigerVeraxa Biotech AG - Post de-SPAC
Baumann Oliver RolfVeraxa Biotech AG - Post de-SPAC
Buergermeister Torsten Georg FriedrichVeraxa Biotech AG - Post de-SPAC
Gruninger MarcVeraxa Biotech AG - Post de-SPAC
Hosseinion WarrenVeraxa Biotech AG - Post de-SPAC
von Halem CarlVeraxa Biotech AG - Post de-SPAC
Willener Raju SudirVeraxa Biotech AG - Post de-SPAC
Ziegler Christoph SamuelVeraxa Biotech AG - Post de-SPAC

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

No transactions on record. Reset filters